Annual Operating Profit
-$36.61 M
-$4.57 M-14.28%
31 December 2023
Summary:
Lumos Pharma annual operaing income is currently -$36.61 million, with the most recent change of -$4.57 million (-14.28%) on 31 December 2023. During the last 3 years, it has fallen by -$5.27 million (-16.80%).LUMO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$7.64 M
+$183.00 K+2.34%
30 September 2024
Summary:
Lumos Pharma quarterly operating income is currently -$7.64 million, with the most recent change of +$183.00 thousand (+2.34%) on 30 September 2024. Over the past year, it has increased by +$2.36 million (+23.63%).LUMO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$36.33 M
+$1.29 M+3.43%
30 September 2024
Summary:
Lumos Pharma TTM operating income is currently -$36.33 million, with the most recent change of +$1.29 million (+3.43%) on 30 September 2024. Over the past year, it has increased by +$285.00 thousand (+0.78%).LUMO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LUMO Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +23.6% | +0.8% |
| 3 y3 years | -16.8% | -16.3% | -15.9% |
| 5 y5 years | -273.0% | -220.3% | -270.1% |
LUMO Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -131.1% | -105.1% | -126.0% |
Lumos Pharma Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.64 M(-2.3%) | -$36.33 M(-3.4%) |
| June 2024 | - | -$7.82 M(-28.0%) | -$37.62 M(-4.6%) |
| Mar 2024 | - | -$10.86 M(+8.6%) | -$39.44 M(+7.7%) |
| Dec 2023 | -$36.61 M(+14.3%) | -$10.00 M(+12.0%) | -$36.61 M(+3.3%) |
| Sept 2023 | - | -$8.93 M(-7.4%) | -$35.45 M(+4.1%) |
| June 2023 | - | -$9.64 M(+20.0%) | -$34.06 M(-15.0%) |
| Mar 2023 | - | -$8.04 M(-9.1%) | -$40.08 M(+0.8%) |
| Dec 2022 | -$32.04 M(+2.2%) | -$8.84 M(+17.0%) | -$39.77 M(+6.0%) |
| Sept 2022 | - | -$7.55 M(-51.8%) | -$37.51 M(+0.1%) |
| June 2022 | - | -$15.65 M(+102.5%) | -$37.45 M(+23.0%) |
| Mar 2022 | - | -$7.73 M(+17.7%) | -$30.46 M(-2.8%) |
| Dec 2021 | -$31.35 M(+19.2%) | -$6.57 M(-12.4%) | -$31.35 M(-1.5%) |
| Sept 2021 | - | -$7.50 M(-13.5%) | -$31.83 M(+1.1%) |
| June 2021 | - | -$8.66 M(+0.5%) | -$31.49 M(+6.0%) |
| Mar 2021 | - | -$8.62 M(+22.2%) | -$29.70 M(+12.9%) |
| Dec 2020 | -$26.30 M(+168.0%) | -$7.05 M(-1.4%) | -$26.30 M(+21.6%) |
| Sept 2020 | - | -$7.16 M(+4.1%) | -$21.63 M(+26.0%) |
| June 2020 | - | -$6.88 M(+31.9%) | -$17.18 M(+33.2%) |
| Mar 2020 | - | -$5.21 M(+118.7%) | -$12.89 M(+31.3%) |
| Dec 2019 | -$9.82 M(-84.3%) | -$2.38 M(-11.6%) | -$9.82 M(-46.6%) |
| Sept 2019 | - | -$2.70 M(+4.0%) | -$18.38 M(-40.2%) |
| June 2019 | - | -$2.60 M(+21.4%) | -$30.72 M(-33.0%) |
| Mar 2019 | - | -$2.14 M(-80.5%) | -$45.87 M(-26.5%) |
| Dec 2018 | -$62.44 M(-14.3%) | -$10.95 M(-27.2%) | -$62.44 M(-4.7%) |
| Sept 2018 | - | -$15.04 M(-15.3%) | -$65.54 M(-8.2%) |
| June 2018 | - | -$17.75 M(-5.1%) | -$71.41 M(+1.5%) |
| Mar 2018 | - | -$18.71 M(+33.1%) | -$70.39 M(-3.4%) |
| Dec 2017 | -$72.88 M | -$14.05 M(-32.8%) | -$72.88 M(+0.1%) |
| Sept 2017 | - | -$20.91 M(+25.0%) | -$72.80 M(+5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | -$16.73 M(-21.1%) | -$68.76 M(-20.6%) |
| Mar 2017 | - | -$21.20 M(+51.7%) | -$86.56 M(-4.6%) |
| Dec 2016 | -$90.76 M(+170.1%) | -$13.97 M(-17.2%) | -$90.76 M(-0.9%) |
| Sept 2016 | - | -$16.87 M(-51.1%) | -$91.61 M(+1.3%) |
| June 2016 | - | -$34.53 M(+36.0%) | -$90.43 M(+25.9%) |
| Mar 2016 | - | -$25.39 M(+71.3%) | -$71.84 M(+113.8%) |
| Dec 2015 | -$33.60 M(-128.6%) | -$14.82 M(-5.5%) | -$33.60 M(-125.8%) |
| Sept 2015 | - | -$15.68 M(-1.6%) | $130.25 M(-2.0%) |
| June 2015 | - | -$15.94 M(-224.1%) | $132.91 M(-4.9%) |
| Mar 2015 | - | $12.85 M(-91.4%) | $139.73 M(+18.8%) |
| Dec 2014 | $117.57 M(-477.6%) | $149.03 M(-1244.1%) | $117.57 M(-398.6%) |
| Sept 2014 | - | -$13.03 M(+42.7%) | -$39.37 M(+14.2%) |
| June 2014 | - | -$9.13 M(-1.9%) | -$34.46 M(+6.3%) |
| Mar 2014 | - | -$9.30 M(+17.6%) | -$32.40 M(+4.1%) |
| Dec 2013 | -$31.14 M(+33.9%) | -$7.91 M(-2.5%) | -$31.14 M(+5.5%) |
| Sept 2013 | - | -$8.12 M(+14.8%) | -$29.52 M(+8.3%) |
| June 2013 | - | -$7.07 M(-12.1%) | -$27.25 M(+2.9%) |
| Mar 2013 | - | -$8.04 M(+27.8%) | -$26.48 M(+13.9%) |
| Dec 2012 | -$23.26 M(+28.8%) | -$6.29 M(+7.6%) | -$23.26 M(+2.1%) |
| Sept 2012 | - | -$5.85 M(-7.2%) | -$22.77 M(+9.0%) |
| June 2012 | - | -$6.30 M(+30.8%) | -$20.89 M(+10.0%) |
| Mar 2012 | - | -$4.82 M(-17.0%) | -$18.99 M(+5.1%) |
| Dec 2011 | -$18.06 M(+8.4%) | -$5.80 M(+46.1%) | -$18.06 M(+9.1%) |
| Sept 2011 | - | -$3.97 M(-9.6%) | -$16.56 M(-6.4%) |
| June 2011 | - | -$4.39 M(+12.9%) | -$17.70 M(+33.0%) |
| Mar 2011 | - | -$3.89 M(-9.5%) | -$13.30 M(+41.4%) |
| Dec 2010 | -$16.66 M(+61.0%) | -$4.30 M(-15.9%) | -$9.41 M(+21.7%) |
| Sept 2010 | - | -$5.11 M(+95.0%) | -$7.73 M(+195.0%) |
| Dec 2009 | -$10.35 M(+9.9%) | -$2.62 M | -$2.62 M |
| Dec 2008 | -$9.41 M | - | - |
FAQ
- What is Lumos Pharma annual operaing income?
- What is the all time high annual operating profit for Lumos Pharma?
- What is Lumos Pharma quarterly operating income?
- What is the all time high quarterly operating profit for Lumos Pharma?
- What is Lumos Pharma quarterly operating profit year-on-year change?
- What is Lumos Pharma TTM operating income?
- What is the all time high TTM operating profit for Lumos Pharma?
- What is Lumos Pharma TTM operating profit year-on-year change?
What is Lumos Pharma annual operaing income?
The current annual operating profit of LUMO is -$36.61 M
What is the all time high annual operating profit for Lumos Pharma?
Lumos Pharma all-time high annual operaing income is $117.57 M
What is Lumos Pharma quarterly operating income?
The current quarterly operating profit of LUMO is -$7.64 M
What is the all time high quarterly operating profit for Lumos Pharma?
Lumos Pharma all-time high quarterly operating income is $149.03 M
What is Lumos Pharma quarterly operating profit year-on-year change?
Over the past year, LUMO quarterly operating income has changed by +$2.36 M (+23.63%)
What is Lumos Pharma TTM operating income?
The current TTM operating profit of LUMO is -$36.33 M
What is the all time high TTM operating profit for Lumos Pharma?
Lumos Pharma all-time high TTM operating income is $139.73 M
What is Lumos Pharma TTM operating profit year-on-year change?
Over the past year, LUMO TTM operating income has changed by +$285.00 K (+0.78%)